New “party pill” test could diagnose ketamine intoxication
Detecting new club drugs is vital for authorities to keep up with trafficking
By Lucy Goodchild van Hilten Posted on 25 November 2015
Almost every month, a new club drug hits dance floors around the world. It’s challenging for authorities to keep up with the influx of new products sold by traffickers; among the weapons in their arsenal are effective tests that can detect the new drugs.
Most recently, a new class of drugs known as “new psychoactive substances” has hit the clubs. Sold online or in smart shops as “legal highs,” these drugs pose a problem for authorities because they’re difficult to analyze – there is currently no standard screening test.
A new test for one club drug, ketamine, can detect it at low levels in urine and plasma, making it faster, easier and cheaper to identify. The authors of a new study published in Journal of Chromatography B say it could give authorities the boost they need to keep up with drug traffickers.
Fighting the influx of new drugs
Ketamine – traditionally an animal tranquilizer – causes users to hallucinate. Used as a date rape drug in recent years, ketamine works as a sedative, provides pain relief and causes memory loss. When people with ketamine intoxication attend hospital emergency services, their symptoms can be mistaken easily for alcohol intoxication, resulting in them being given the wrong treatment.
It is vital to develop new tests to detect psychoactive substances, in order to keep up with – and even get ahead of – trends in drug use. The new study describes, for the first time, a fast, simple and fully validated method to detect ketamine in urine and plasma.
“These drugs are difficult to analyze – we see a lot of versatility in the molecules and new drugs are appearing almost every month; traffickers are always one step ahead of the authorities,” said toxicology professor Dr. Eugenia Gallardo, lead author of the study from Universidade da Beira Interior in Portugal. “Analytical methods for detecting drugs in biological samples play a decisive role and their reliability is a matter of great significance in forensic and clinical toxicology.”
New psychoactive drugs
So-called “legal highs” are raising concern worldwide.
- Fast moving: New versions of the drugs appear as soon as the authorities are able to ban them.
- Prolific: In Europe, 255 novel psychoactive substances (NPS) were detected between 2012 and 2014.
- Copycats: The biggest groups of NPS are synthetic cannabimimetics and synthetic cathinones.
- Evasive: Most NPS are metabolized to below detection point, so tests have to look for the molecules they are broken down into.
- Disguised: Many products are labeled “not for human consumption” but are designed to provide similar highs to illegal drugs.
The research is the result of a collaboration between toxicologists at Universidade da Beira Interior in Portugal and forensic scientists at Instituto Nacional de Medicina Legal e Ciências Forenses in Portugal and Universidad de Santiago de Compostela in Spain.
A new approach to testing
The new test uses a method called gas chromatography-tandem mass spectrometry (GC–MS/MS), which is often used in drug detection, fire investigation and environmental analysis.
The researchers extracted ketamine and the main substance produced when it breaks down, called norketamine, from 0.25mL of urine and plasma samples.
Using the new method, they could detect amounts of the drug as low as 5 nanograms per milliliter. Being able to detect the drug at low levels in such small samples is helpful for forensic labs, since it means they would be able to run multiple tests on a single sample. What’s more, the test only takes about 30 minutes from start to finish, making analysis faster and helping doctors ensure the right treatment is administered.
“These low limits of detection and the quite high amounts of the compounds extracted from very small samples make this procedure suitable for laboratories performing routine analysis in the field of forensic toxicology,” said Dr. Gallardo. “Compared with existing methods, our new procedure is faster and more cost effective.”
Read the study
Elsevier has made this article free access until February 17, 2016:
Ivo Moreno et al: “Determination of ketamine and its major metabolite, norketamine, in urine and plasma samples using microextraction by packed sorbent and gas chromatography-tandem mass spectrometry,” Journal of Chromatography B (November 2015)
Dr. Eugenia Gallardo is Professor of Toxicology at the University of Beira Interior, Covilhã, Portugal. She obtained her PhD in Forensic Medicine from the University of Santiago de Compostela, Spain, in 2006. Her main areas of interest and research are the development of analytical methods for drug analysis in biofluids with special focus on new and solventless extraction procedures (SPME, LLME and MEPS). She has published a number of papers and reviews in international peer reviewed journals and is the supervisor of several MSc and PhD theses.
The Journal of Chromatography B publishes papers on developments in separation science relevant to biology and biomedical research, including both fundamental advances and applications. The journal considers analytical techniques, including chromatography, electrophoresis and related methods, affinity and immunoaffinity-based methodologies, hyphenated and other multi-dimensional techniques, and microanalytical approaches. The journal also considers articles reporting developments in sample preparation, detection techniques including mass spectrometry, and data handling and analysis.
Elsevier Connect Contributor
After a few accidents, Lucy Goodchild van Hilten discovered that she’s a much better writer than a scientist. Following an MSc in the History of Science, Medicine and Technology at Imperial College London, she became Assistant Editor of Microbiology Today. A stint in the press office at Imperial saw her stories on the front pages, and she moved to Amsterdam to work at Elsevier as Senior Marketing Communications Manager for Life Sciences. She’s now a freelance writer at Tell Lucy. Tweet her @LucyGoodchild.
By Lucy Goodchild van Hilten | Posted on 28 Oct 2015
E-cigarette use has knock-on effects, like increased alcohol use and exposure to chemicals from aerosol, research suggestsBy David Levine | Posted on 26 Feb 2015
Experts weigh in on the promise – and problems – of electronic cigarettesBy Eileen Leahy | Posted on 29 Jan 2015
In Mayo Clinic Proceedings, experts urge drastic reductions in the consumption of added sugarsBy David Levine | Posted on 02 May 2014
Panelists and governor address health journalists at AHCJ conference in Colorado – and delegates visit a dispensaryBy Eileen Leahy | Posted on 08 Jan 2014
Perceived benefits of electronic cigarettes may lead to higher experimentation rates, study findsBy David Levine | Posted on 26 Nov 2013
Ninety percent of major diseases are related to aging; understanding the genetics of aging is key to a longer and healthier lifeBy Mary Beth O'Leary | Posted on 14 Nov 2013
Findings could ultimately lead to therapies to help people quit smoking, say researchers in Current Biology